Innovative air cleaning leader conducts a series of tests to show efficacy of DFS technology.
Pulaski, NY, August 11, 2020– In response to the COVID-19 Pandemic, HealthWay Family of Brands has conducted a series of tests to show the efficacy of DFS technology on the capture and permanent removal of airborne viruses and bacteria. World-renowned Infection Control expert and an advisor to the U.S. EPA (Environmental Protection Agency) and the World Health Organization, Dr. Syed Sattar, conducted his studies in a chamber that was built to follow U.S. EPA guidelines.
DFS technology was proven to remove from the air a proxy virus for SARS-CoV-2 (RNA virus MS2)1: The results of this data show 99.987% elimination in 10 minutes of the surrogate which is .03 micron in size. The test also showed that there was 100% elimination in 45 minutes and again 100% at 24 hours indicating no reintroduction of the proxy virus. The bacteriophage MS-2 is a small (about 30 nanometers or .03 micron), non- enveloped virus, which is often used as a surrogate for small, non-enveloped human pathogenic viruses such as noroviruses.
About HealthWay Family of Brands
For over 40 years, HealthWay Family of Brands has been reimagining the world as a better, safer place with innovative air purification technologies. Our solutions are crafted in the USA and trusted everywhere air quality matters. Indoor air quality problems come in all shapes and sizes - we’re proud that our industry-leading patented DFS (Disinfecting Filtration System) technology is being used in cleanroom applications, hospital surgical suites, commercial office buildings, hotels, schools, universities and many mission-critical environments around the globe. To learn more, contact Christian Cobb at email@example.com.